AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers
BloombergDuration: 3:41
Read the full storyUp next
- Robinhood in 'Food Fight' for Anthropic IPO Retail Allocation
- NYC Marathon Winner Andreas Almgren on Debut Victory
- 'No Moderates Left' in GOP Says DCCC Chair Suzan DelBene
- Dems See 'Tremendous Momentum' in Michigan, Says Siena's Don Levy
- AI Will Create 'Weird' Economic Benefits: Manidis
- Mendler's Northwood Reaches $2 Billion Valuation
